CN106511931A - Traditional Chinese medicinal formula for treating myocardial infarction - Google Patents
Traditional Chinese medicinal formula for treating myocardial infarction Download PDFInfo
- Publication number
- CN106511931A CN106511931A CN201611047172.XA CN201611047172A CN106511931A CN 106511931 A CN106511931 A CN 106511931A CN 201611047172 A CN201611047172 A CN 201611047172A CN 106511931 A CN106511931 A CN 106511931A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- myocardial infarction
- medicine formula
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal formula for treating myocardial infarction. The formula comprises 2 g of unprocessed Radix Aconiti, 6 g of Chinese prickly ash, 3 g of aconite root, 6 g of dry ginger, 6 g of red halloysite, 9 g of Chinese angelica root, 9 g of Manchurian wildginger, 6 g of honey-fried licorice root, 6 g of Ricepaperplant Pith and 25 jujubes. A preparation and use method of a traditional Chinese medicinal composition is characterized in that above raw medicines are decocted in water, obtained decoction is taken one dose every day for 7 days to complete a treatment course, and the decoction is taken for 2-6 treatment courses.
Description
Technical field
The invention belongs to Chinese medicine composition, specifically, is to be related to a kind of Chinese medicine formula for treating myocardial infarction.
Background technology
Myocardial infarction is mainly expanded by heart circle, and heart rate is fast, and apex decreased loudness of first sound may occur in which fourth heart sound galloping horse
Rule, had pericardial friction rub at 2~3 days more.Apical region of heart may occur in which coarse systolic murmur or barlow syndrome, be two
Caused by cusp dysfunction of papillary muscle or fracture, there can be various arrhythmia.Blood pressure is reduced.Can have with arrhythmia, shock or
Other related signs of heart failure.The patient clinical that myocardial infarction occurs often has violent chest pain, and the persistent period is long, rests or buccal nitre
Acid glycerol piece can not be allowed to alleviate, and with the performance such as fear, dying sense, sensation of asphyxia and dripping sweat, dysphoria, can have not
Gram, arrhythmia and heart failure even die suddenly.Symptom is treated Western medicine, it is impossible to the effectively treatment disease more, and controlled using Chinese herbal medicine
Treat, with safe and effective advantage.
The present invention is used for the Chinese medicine formula for treating myocardial infarction nursing, for myocardial infarction etiology and pathogenesis, with heat-clearing and toxic substances removing,
Clearing away heat-damp and promoting diuresis, cleaning heat and expelling wind, restore menstrual flow and invigorate blood circulation, promoting the circulation of blood detumescence, promoting blood circulation to remove blood stasis, resolving mass and removing the obstruction of the collateral are the rule for the treatment of, reach cold expelling warming YANG, promote blood circulation
Pain relieving, treats effect of myocardial infarction.
The content of the invention
Present invention aim to address the problem in prior art, it is special provide a kind of effect substantially, the course for the treatment of is shorter controls
Treat the Chinese medicine formula of myocardial infarction.
In order to realize foregoing invention purpose, the present invention makes the raw material composition and its weight proportion of the effective ingredient
For:Radix Aconiti 2g, Pericarpium Zanthoxyli 6g, Radix Aconiti Lateralis Preparata 3g, Rhizoma Zingiberiss 6g, Halloysitum Rubrum 6g, Radix Angelicae Sinensis 9g, Herba Asari 9g, Radix Glycyrrhizae Preparata 6g, Medulla Tetrapanacis 6g, Fructus Jujubae
25 pieces.
The preparation and application of Chinese medicine composition of the present invention:It is decocted in water for oral dose:Daily 1 dose, 7 doses is a course for the treatment of, needs medication
The 2-6 courses for the treatment of.
Invent for treating the Chinese medicine formula of myocardial infarction, select natural drug, for myocardial infarction etiology and pathogenesis, each taste
Medical material respectively has its effect, coordinates mutually, and in side, Radix Aconiti, Radix Aconiti Lateralis Preparata activate yang and dissipate the moon, the smooth beniol heart;Pericarpium Zanthoxyli warming spleen and stomach for dispelling cold, dissipating fluid-retention damp eliminating;
Rhizoma Zingiberiss are promoted blood circulation by cold warming YANG, warming middle-JIAO;Halloysitum Rubrum benefit painstaking effort, yin fluid astringing gas;Radix Angelicae Sinensis blood circulation promoting and enriching, passages through which vital energy circulates tonneau;Radix Paeoniae Alba pain relieving emergency,
Chinese Angelica blood replonishing is helped to enrich blood;Fructus Jujubae, Radix Glycyrrhizae Preparata strengthening QI of middle-JIAO, stomach function regulating spleen invigorating, and mediation property of medicine.Above-mentioned all herbal medicines are shared, mutually
Collaboration brings out the best in each other, play altogether heat-clearing and toxic substances removing, clearing away heat-damp and promoting diuresis, cleaning heat and expelling wind, restore menstrual flow and invigorate blood circulation, promoting the circulation of blood detumescence, promoting blood circulation to remove blood stasis, eliminating stagnation lead to
The effect of network, reaches cold expelling warming YANG, and coronary circulation-promoting pain-relieving treats effect of myocardial infarction.
Specific embodiment
Embodiment 1:A kind of Chinese medicine formula for treating myocardial infarction, by weight including following Chinese medicine ingredients:Raw river
Black 2g, Pericarpium Zanthoxyli 6g, Radix Aconiti Lateralis Preparata 3g, Rhizoma Zingiberiss 6g, Halloysitum Rubrum 6g, Radix Angelicae Sinensis 9g, Herba Asari 9g, Radix Glycyrrhizae Preparata 6g, Medulla Tetrapanacis 6g, 25 pieces of Fructus Jujubae.
Embodiment 2:If patient has heat very symptom, add Radix Ginseng 20g, Rhizoma Atractylodis Macrocephalae 10g in said components.
Embodiment 3:If patient has silt very symptom, the attached 10g of perfuming, Fructus Aurantii Immaturus 5g in said components.
Embodiment 4:If patient has pain symptom, Oletum Trogopterori 6g, Radix Salviae Miltiorrhizae 5g, Pollen Typhae 7g in said components.
It is decocted in water for oral dose:Daily 1 dose, 7 doses is a course for the treatment of, needs the medication 2-6 courses for the treatment of.
The clinical treatment effect of the Chinese medicine formula for myocardial infarction nursing of the present invention is illustrated below by way of practical example
Really.
1st, clinical data
50 myocardial infarction patients, 45 ± 20 years old patient's mean age (25~65 years old), meet "《Chinese medical disease diagnoses curative effect mark
It is accurate》Myocardial infarction diagnosis standard in (State Administration of Traditional Chinese Medicine's promulgation) ", full diagnostics is myocardial infarction patient.
50 myocardial infarction patients all have the symptoms such as chest pain, arrhythmia, heart failure.
Criterion of therapeutical effect
Cure:Clinical symptom disappearance, cardiac muscle detection are normal;
It is effective:Clinical symptoms substantially mitigate, and patient's rhythm of the heart is neat, painless;
It is invalid:, without substantially mitigation, exacerbation of symptoms, it is invalid to be judged to for clinical symptoms.
3rd, therapeutic outcome
After 50 myocardial infarction patients treat 3~4 courses for the treatment of, cure 38, treat effective 8, invalid 2.Treatment total effective rate
For 93%.
Typical case:
In certain, male, patient seek medical advice before before without obvious inducement, there is suddenly chest pain, painful area based on pareordia, pain model
About hand size is enclosed, in squeezing sample pain, with whole body profuse sweating, cardiopalmus, shoulder back and bottleneck throat radiating pain, without Nausea and vomiting, nothing
Uncomfortable in chest, shortness of breath, weak, since cough, expectoration, spitting of blood, patient idiopathy, psychentonia does not enter diet, and urine is normal, not
Bowel movement.The past body is good for, and denies the medical histories such as hypertension, diabetes, hepatitis, tuberculosis, denies wound, operation, blood transfusion history, denies medicine
Thing and food anaphylaxiss history, deny harmful substance and special physico-chemical toxicant exposure history, and history of preventive inoculation is unknown.Take inventive formulation
6 doses, it is decocted in water for oral dose, daily 1 dose, daily 3 clothes.Second examines:Pain slightly feels mitigation, 12 doses of following the service, and three examine:Pain basic solution is removed, it
Afterwards, it is after treatment effect, advises and continue to take 12 doses.Follow-up 1 year, all goes well.
Claims (4)
1. a kind of Chinese medicine formula for treating myocardial infarction, it is characterised in that:The Chinese medicine formula includes following Chinese medicine by weight
Composition:Radix Aconiti 2g, Pericarpium Zanthoxyli 6g, Radix Aconiti Lateralis Preparata 3g, Rhizoma Zingiberiss 6g, Halloysitum Rubrum 6g, Radix Angelicae Sinensis 9g, Herba Asari 9g, Radix Glycyrrhizae Preparata 6g, Medulla Tetrapanacis 6g, greatly
25 pieces of Fructus Jujubae.
2. the Chinese medicine formula of myocardial infarction is treated as claimed in claim 1, it is characterised in that:The Chinese medicine formula also includes Radix Ginseng
20g, Rhizoma Atractylodis Macrocephalae 10g.
3. the Chinese medicine formula of myocardial infarction is treated as claimed in claim 1, it is characterised in that:The Chinese medicine formula also includes Rhizoma Cyperi
10g, Fructus Aurantii Immaturus 5g.
4. the Chinese medicine formula of myocardial infarction is treated as claimed in claim 1, it is characterised in that:The Chinese medicine formula is also clever including five
Fat 6g, Radix Salviae Miltiorrhizae 5g, Pollen Typhae 7g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611047172.XA CN106511931A (en) | 2016-11-25 | 2016-11-25 | Traditional Chinese medicinal formula for treating myocardial infarction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611047172.XA CN106511931A (en) | 2016-11-25 | 2016-11-25 | Traditional Chinese medicinal formula for treating myocardial infarction |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106511931A true CN106511931A (en) | 2017-03-22 |
Family
ID=58357857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611047172.XA Withdrawn CN106511931A (en) | 2016-11-25 | 2016-11-25 | Traditional Chinese medicinal formula for treating myocardial infarction |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106511931A (en) |
-
2016
- 2016-11-25 CN CN201611047172.XA patent/CN106511931A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1302805C (en) | Ready prepared Chinese medicine for preventing and treating brain apoplexia | |
CN100488549C (en) | Externally applied medicament for treating rheumatism | |
CN101108226A (en) | Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness | |
CN103083556B (en) | Traditional Chinese medicine for treating cervical spondylosis | |
CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
CN104771652A (en) | Vertigo treating traditional Chinese medicine composition | |
CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
CN106511931A (en) | Traditional Chinese medicinal formula for treating myocardial infarction | |
CN104547973A (en) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof | |
CN102836241A (en) | Traditional Chinese medicine combination for treating neck shoulder lumbocrural pains caused by spinal degenerative change | |
CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
CN102614479A (en) | Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma | |
CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN106729521A (en) | It is a kind of to treat Chinese medicine preparation of apoplexy and preparation method thereof | |
CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
CN104623333A (en) | Drug for treating facial paralysis | |
CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170322 |
|
WW01 | Invention patent application withdrawn after publication |